Report Description Table of Contents Introduction In 2021, the valuation of the global artificial cornea and corneal implant market was USD 421 million. It is predicted to reach USD 642 million by 2027, projecting a CAGR of 6.9 percent throughout 2021-2027. The method of artificial cornea transplantation involves suturing of natural cornea tissue from a donor’s eye to replace a specific layer of the cornea. However, there is a global shortage of cornea donors, eye and tissue bankingsince these are not prevalent in various countries. Meanwhile, there is always a risk that the human eye will reject the process of transplantation, resulting in infection or visual loss. Cornea implants treat keratoconus, degenerative conditions, and many more. Keratoconus is a condition of the eye cornea’s structure, causing vision loss and affects about one in every 2,000 people, usually starting in puberty and progressing into the mid-30s. In addition, an artificial cornea may be supplied to individuals who are having repeated corneal grafts failure. A keratoprosthesis (KPro) is an artificial cornea material implant made of synthetic or prosthetic material. The Boston keratoprosthesis (Boston KPro) is the most prevalent one. In other terms, it is a surgical process involving replacing a defective cornea with an artificial cornea. Usually, keratoprosthesis is indicated after one or more donor corneal transplants have failed.Polymerslike silica are used to create artificial cornea tissue. Artificial cornea implants are of two types, i.e., Synthetic cornea implants and biosynthetic cornea implants. The effects of Covid-19 on artificial corneas and corneal transplants implant market Due to lockdowns and limits enacted to prevent the spread of the COVID-19 epidemic, the number of patient visits to clinics decreased significantly in the first and second quarters of 2020. As a result, Hospitals and clinics perform fewer elective eye procedures each week than they did in the past. According to an article in Ophthalmology Times, elective procedures have decreased from 200 to only ten each week. In addition, in countries such as the United States, patient visits to examination facilities havebeen reduced by 15%. According to the same article, it was reported that ophthalmology suffered aconsiderable loss of patient volume during the coronavirus disease (COVID-19) pandemic. During the starting phases of the COVID-19 outbreak, the worldwide government-imposed restrictions and prohibitions on medical operations and elective surgeries to restrict the virus’s contamination. Due to these restrictions, artificial cornea makers struggled to give in-person product presentations, operate at total capacity, and attend or organize conferences. Furthermore, due to lockdown in APAC nations such as China and India, the shipment & production of ophthalmic were delayed; these restrictions hindered the demand for ophthalmic surgeries. Market Dynamics Globally, the number of people suffering from severe eye disorders rises, and vision loss is becoming a significant public health concern. The prevalence of eye diseases such as diabetic retinopathy and ocular hypertension has increased due to the rising number of chronic diseases such as diabetes and hypertension (glaucoma) coupled with aging.In addition, the number of people who are blind or have limited eyesight is also predicted to rise significantly. Market Drivers: increasing incidences of corneal blindness, eye injury, and scare number of cornea donors driving the growth of the market Corneal blindness affects around 10 million individuals on a worldwide basis. As a result, the critical factor driving the expansion of artificial cornea implants isthe increased incidence of corneal blindness. Furthermore, the scarcity of human cornea donors has contributed to the market’s rapid development. Moreover, when the number of trauma cases rises, there is a greater risk of eye injury, which will drive the market forward. The chance of nerve regeneration following a human donor cornea transplant is low, whereas a biosynthetic cornea implant has a high probability of nerve regeneration after implantation.In heavily populated regions like India, donors for corneas are scarce, and the patients with corneal blindness must wait for a long time for corneal transplants. Around 6.8 million people in the country have poor vision in one eye due to corneal abnormalities, while approximately one million people have poor vision in both eyes. Restraint: Rejection of alloplastic artificial corneas and the costly implant surgery set to limit the market growth The human eye’s rejection of alloplastic artificial corneas will be a significant problem that will limit the global market for artificial cornea implants. Furthermore, because artificial cornea implant surgery is a costly procedure, the adoption is minimal in emerging nations, which will stifle the market growth throughout the forecasted period. Furthermore, the scarcity of human cornea donors and the high risk of grafting artificial cornea implants have significantly impacted the global market. Patients and the end-users will have to pay a premium for OCT diagnostic services and OCT angiography. According To Ophthalmology Magazine, the OCT tests are used in 3–12% of the total visits in a typical general ophthalmology practice. In addition, the expenditures of equipment upkeep, staffing, and training are all substantial. These factors influence the clinic’s and small diagnostic center’s purchase decisions for such expensive equipment, and hence the market growth is expected to be limited. Opportunity: The increasing demand for artificial cornea and its implant and the technological enhancement in the same set to provide various opportunities in the market The high prevalence of corneal blindness, along with a scarcity of corneal donors, is predicted to provide high-growth possibilities for corneal implant producers.Furthermore, because of the rising frequency of corneal infection, the artificial cornea implant market is expected to rise exponentially throughout the forecast period. In addition, the demand for these cornea implants has grown in the global market due to increased visual handicaps among working people due to clouded corneas. Segmentation Analysis According to the report, the market is classified into the following segments and sub-segments: By Implantation Type Endothelial Keratoplasty Penetrating Keratoplasty Others By Disease manifestation Keratoconus Fungal Keratitis Fuchs’ Dystrophy Others By Type Artificial Cornea Human Cornea By End-User Specialty Clinics & ASCs Hospitals By Region North America U.S. Canada Mexico Europe Germany France Italy Switzerland U.K. Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Israel South Africa Saudi Arabia Rest of LAMEA The ‘human cornea’ sector accounts for the largest Artificial Cornea and Corneal Implant market share by type. This market segment is predicted to spread awareness about corneal implantation and eye tissue donation, particularly in emerging countries.The ‘penetrating keratoplasty’ sector dominates the market based on the Implantation Type. Penetrating Keratoplasty dominates due to an increase in the number of patients with eye illnesses such as infectious keratitis and eyeball injury. By Disease manifestation, which is one of the segments, the ‘Fuchs’ dystrophy’ segment has the largest market share. Due to the increased prevalence of Eyerelated diseases and increased awareness among people about the early detection of the condition, this segment is predicted to develop rapidly. The market is dominated by the ‘specialty clinics’ category based on the End-User. The decline in inpatient surgeries and the increasing preference for more minor invasive procedures contribute to this segment’s development. Patient preferences are fueling the segment’s rise for effective treatment and worries about hospital-acquired illnesses. Most ambulatory surgical institutions prefer biosynthetic cornea implants rather than synthetic cornea implants. As a result, the worldwide artificial corneal implant market is likely to dominate biosynthetic corneal implants. Report Attribute Details Forecast Period 2020 - 2028 Market size value in 2020 USD 421 Million Revenue forecast in 2028 USD 642 Million Growth rate CAGR of approximately 6.9% Base year for estimation 2020 Historical data 2015 – 2019 Unit USD Billion, CAGR (2020 - 2028) Segmentation By Implantation Type, By Disease manifestation, By Type , By Application, By Region. By Implantation Type Endothelial Keratoplasty, Penetrating Keratoplasty, Others. By Disease Manifestation Keratoconus, Fungal Keratitis, Fuchs’ Dystrophy, Others. By Type Artificial Cornea, Human Cornea. By End-User Specialty Clinics & ASCs, Hospitals. By Region North America, Europe, Asia-Pacific, LAMEA. Country Scope U.S. , Canada , France, Germany ,U.K. , China , Japan , India , South Korea, Mexico, Brazil ,U.A.E. etc. Company Usability Profiles CorneaGen, AJL Ophthalmic, LinkoCare Life Sciences AB, Addition Technology, Mediphacos, Florida Lions Eye Bank, Presbia plc, Aurolab, EyeYon Medical, Advancing Sight Network, Massachusetts Eye and Ear, DIOPTEX GmbH, San Diego Eye Bank, SightLife, Cornea Biosciences. Pricing and purchase options Avail customized purchase options to meet your exact research needs. Regional Analysis: ‘North America’ has the largest share of the market by region. North America’s significant proportion is due to the region’s developed healthcare infrastructure, increased acceptance of sophisticated medical technologies, and a diverse presence of corneal implant manufacturers. Furthermore, because ofthe large population base, rising disposable income, and increased patient awareness of eye care, Asia-Pacific is predicted to grow fastest over the forecasted period. Competitive Analysis Key market players operating in the market include CorneaGen, AJL Ophthalmic, LinkoCare Life Sciences AB, Addition Technology, Mediphacos, Florida Lions Eye Bank, Presbia plc, Aurolab, EyeYon Medical, Advancing Sight Network, Massachusetts Eye and Ear DIOPTEX GmbH, San Diego Eye Bank, SightLife, Cornea Biosciences, Recent Developments In June 2020, AJL Ophthalmic acquired CE Mark clearance for ENDO-K PRO. As a result, the end-users will access the company’s portfolio once it has been approved. In January 2020, Mediphacos introduced Keraring Intrastromal Corneal. In consequence, the corporation will have the ability togain a higher market share due to the product launch. Frequently Asked Question About This Report Which artificial cornea and corneal implant market, by type, have been included in this report? By type Penetrating Keratoplasty and Endothelial Keratoplasty have been included in this report. Which geographical region is dominating in the artificial cornea and corneal implant market? North America is dominating in the market. Which are the leading transplant type in the artificial cornea and corneal implant market? Penetrating Keratoplasty is the leading transplant type in the market. Which is the leading disease indication segment of the artificial cornea and corneal implant market? Fuchs Dystrophy is the leading disease indication segment of the market. Which is the leading end-user segment of the artificial cornea and corneal implant market? Specialty clinics are the leading end-user segment of the market. What will be the artificial cornea and corneal implant market size in 2027? It is predicted to reach USD 642 million by 2027. N/A Chapter 1. Introduction 1.1 Study Objectives 1.2 Market Definition Table 1 Inclusions and Exclusions 1.3 Study Scope 1.3.1 Markets Covered Figure 01: Artificial Cornea and Corneal Implant Market Segmentation 1.3.2 Geographic Scope Figure 02: Artificial Cornea and Corneal Implant Market Geography covered 1.3.3 Years Considered 1.4 Stakeholders Chapter 2. Research Methodology 2.1 Data Procurement 2.2 Paid Database 2.2.1 Secondary Data 2.1.2.1 Key Secondary sources 2.2.2 Primary Data 2.2.2.1 Primary sources 2.2.2.2 Key industry insights 2.2.2.3 Primary interviews with experts 2.2.2.4 Key primary respondent list 2.3 Market Size Estimation 2.4 Bottom-Up and Top-Down Approaches 2.4.1 Bottom-Up Approach 2.4.1.1 Approach for arriving at market size by bottom-up analysis Figure 03: Artificial Cornea and Corneal Implant Market: Bottom-Up Approach 2.4.2 Top-Down Approach 2.4.2.1 Approach for Capturing Market Size by Top-Down Analysis Figure 04: Artificial Cornea and Corneal Implant Market: Top-Down Approach 2.5 Market Breakdown and Data Triangulation Figure 05: Data Triangulation 2.6 Research Methodology 2.7 Risk Assessment Table 2: Risk Assessment Chapter 3. Executive Summary 3.1 Artificial Cornea and Corneal Implant Market: Post-Covid-19 Figure 06: Impact of Covid-19 on Artificial Cornea and Corneal Implant Market 3.1.1 Actual Scenario Figure 07: Realistic Scenario: Artificial Cornea and Corneal Implant Market, 2020–2028 (USD Million) 3.1.2 Pessimistic Scenario Figure 08: Pessimistic Scenario: Artificial Cornea and Corneal Implant Market, 2020–2028 (USD Million) 3.1.3 Optimistic Scenario Figure 09: Optimistic Scenario: Artificial Cornea and Corneal Implant Market, 2020–2028(USD Million) 3.1.4 Market Summary Figure 10: Human Cornea to Witness Highest CAGR in Artificial Cornea and Corneal Implant Market, By Type, During Forecast Period Figure 11: Specialty clinics to Witness Higher CAGR in Artificial Cornea and Corneal Implant Market for End-User Segment during Forecast Period Figure 12: Fuchs’ dystrophy for Disease manifestation to Register Highest CAGR in Artificial Cornea and Corneal Implant Market during Forecast Period Figure 13: Penetrating Keratoplasty for Implantation Type to Register Highest CAGR in Artificial Cornea and Corneal Implant Market during Forecast Period Figure 14: North America to Account for Largest Share of Global Artificial Cornea and Corneal Implant Market In 2020 Chapter 4. Market Definitions 4.1 Market Segmentation Figure 15: Artificial Cornea and Corneal Implant Market Segmentation Chapter 5. Industry Outlook 5.1 Market Snapshot 5.2 Global Artificial Cornea and Corneal Implant Market 5.2.1 Global Artificial Cornea and Corneal Implant market, 2020 – 2028 (USD Million) 5.3 Regional Segment Analysis 5.3.1 Global Artificial Cornea and Corneal Implant market, by region, 2020 - 2028 (USD Million) 5.4 Type Segment Analysis 5.4.1 Global Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 5.5 End-User Analysis 5.5.1 Global Artificial Cornea and Corneal Implant market, By End-User, 2020 - 2028 (USD Million) 5.6 Disease manifestation Segment Analysis 5.6.1 Global Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 5.7 By Disease manifestation Business Analysis 5.8 Value Chain Analysis 5.9 Market Variable Analysis 5.9.1 Market Drivers Analysis 5.9.2 Market Restraints Analysis 5.10 Business Environment Analysis Tool 5.10.1 Artificial Cornea and Corneal Implant market PEST analysis 5.10.2 Artificial Cornea and Corneal Implant market Porter’s analysis 5.11 Penetration & Growth Prospect Mapping Chapter 6. Market Overview 6.1 Introduction 6.2 Market Dynamics Figure 16 Artificial Cornea and Corneal Implant Market: Drivers, Restraints, Opportunities, and Challenges 6.2.1 Drivers Figure 17 Artificial Cornea and Corneal Implant Market Drivers and Their Impact 6.2.2 Restraints Figure 18 Artificial Cornea and Corneal Implant Market Restraints and Their Impact 6.2.3 Opportunities Figure 19 Artificial Cornea and Corneal Implant Market Opportunities and Their Impact 6.2.4 Challenges Figure 20 Artificial Cornea and Corneal Implant Market Challenges and Their Impact 6.3 Impact of Covid-19 on Artificial Cornea and Corneal Implant Market 6.4 Value Chain Analysis Figure 21 Value Chain Analysis: Artificial Cornea and Corneal Implant Market 6.5 Ecosystem Figure 22 Artificial Cornea and Corneal Implant Market: Ecosystem Table 3 Artificial Cornea and Corneal Implant Market: Ecosystem Figure 23 Revenue Shift in Artificial Cornea and Corneal Implant Market 6.6 Patent Analysis Table 4 Number of Patents Registered in Artificial Cornea and Corneal Implant Market in USA in Last 9 Years Figure 24 Top 15 Companies with Highest No. of Patents in Last 9 Years Figure 25 No of Patents Granted Per Year, 2019–2020 Table 5 List of Global Patents in Artificial Cornea and Corneal Implant Market 6.7 Trade Analysis Figure 26 Import Data for Artificial Cornea, By Country, 2016–2020 (USD Thousand) Table 6 Import Data for Human Cornea, By Country, 2016–2020 (USD Thousand) Figure 27 Export Data for Artificial Cornea, By Country, 2016–2020 (USD Thousand) Table 7 Export Data for Human Cornea, By Country, 2016–2020 (USD Thousand) 6.8 Tariff Analysis 6.9 Case Study Analysis 6.10 Porter’s Five Forces Analysis Table 8 Artificial Cornea and Corneal Implant Market: Porter’s Five Forces Analysis, 2020 6.10.1 Threat of New Entrants 6.10.2 Threat of Substitutes 6.10.3 Bargaining Power of Buyers 6.10.4 Bargaining Power of Suppliers 6.10.5 Degree of Competition 6.11 Technology Analysis 6.11.1 Trends in Technology (2014-2020) 6.11.2 Trends in Technology (2021-2028) Table 9 Key Regulations: Artificial Cornea and Corneal Implant Market 6.12 Pricing Analysis 6.12.1 Average Price Trend Analysis (By region, By Countries) Chapter 7. Competitive & Vendor Landscape 7.1 Company Market Share Analysis Table 10: Key Players market share Figure 28: Key players market share of companies 7.2 Manufacturers Artificial Cornea and Corneal Implant Manufacturing Sites, Area Served, Product Type 7.3 Artificial Cornea and Corneal Implant Market Competitive Situation and Trends 7.4 Manufacturers Mergers & Acquisitions, Expansion Plans Chapter 8. Global Artificial Cornea and Corneal Implant Market: Type Segment Analysis 8.1 Introduction 8.2 Sales Volume & Revenue Analysis (2020-2028) Table 11 Artificial Cornea and Corneal Implant Market, By Type, 2021–2028 (USD Million) Figure 29 Artificial Cornea and Corneal Implant Market, By Type Figure 30 Human Cornea Segment to Register Highest CAGR in Artificial Cornea and Corneal Implant Market During Forecast Period 8.3 Human Cornea 8.3.1 Human Cornea market, 2020 - 2028 (USD Million) Figure 31: Human Cornea market, 2020 - 2028 (USD Million) 8.4 Artificial Cornea 8.4.1 Artificial Cornea market, 2020 - 2028 (USD Million) Figure 32: Artificial Cornea market, 2020 - 2028 (USD Million) Chapter 9. Global Artificial Cornea and Corneal Implant Market: End-User Segment Analysis 9.1 Introduction 9.2 Sales Volume & Revenue Analysis (2020-2028) Table 12: Artificial Cornea and Corneal Implant Market, By End-User, 2021–2028 (USD Million) Figure 33: Artificial Cornea and Corneal Implant Market, By End-User, 2021–2028 (USD Million) Figure 34: Specialty Clinics Segment to Register Highest CAGR in Artificial Cornea and Corneal Implant Market during Forecast Period 9.3 Specialty Clinics & ASCs 9.3.1 Specialty Clinics & ASCs market, 2020 - 2028 (USD Million) Figure 35: Specialty Clinics & ASCs market, 2020 - 2028 (USD Million) 9.4 Hospitals 9.4.1 Hospitals market, 2020 - 2028 (USD Million) Figure 36: Hospitals market, 2020 - 2028 (USD Million) Chapter 10. Global Artificial Cornea and Corneal Implant Market: Disease manifestation Segment Analysis 10.1 Introduction 10.2 Sales Volume & Revenue Analysis (2020-2028) Table 13: Artificial Cornea and Corneal Implant Market, By Disease manifestation, 2021–2028 (USD Million) Figure 37: Artificial Cornea and Corneal Implant Market, By Disease manifestation, 2021–2028 (USD Million) Figure 38: Fuchs’ dystrophy Segment to Register Highest CAGR in Artificial Cornea and Corneal Implant Market during Forecast Period 10.3 Keratoconus 10.3.1 Keratoconus market, 2020 - 2028 (USD Million) Figure 39: Keratoconus market, 2020 - 2028 (USD Million) 10.4 Fungal Keratitis 10.4.1 Fungal Keratitis market, 2020 - 2028 (USD Million) Figure 40: Fungal Keratitis market, 2020 - 2028 (USD Million) 10.5 Fuchs’ Dystrophy 10.5.1 Fuchs’ Dystrophy market, 2020 - 2028 (USD Million) Figure 41: Fuchs’ Dystrophy market, 2020 - 2028 (USD Million) 10.6 Others 10.6.1 Other Disease manifestation market, 2020 - 2028 (USD Million) Figure 42: Other Disease manifestation market, 2020 - 2028 (USD Million) Chapter 11. Global Artificial Cornea and Corneal Implant Market: Implantation Type Segment Analysis 11.1 Introduction 11.2 Sales Volume & Revenue Analysis (2020-2028) Table 14: Artificial Cornea and Corneal Implant Market, By Implantation Type, 2021–2028 (USD Million) Figure 43: Artificial Cornea and Corneal Implant Market, By Implantation Type, 2021–2028 (USD Million) Figure 44: Penetrating Keratoplasty Segment to Register Highest CAGR in Artificial Cornea and Corneal Implant Market during Forecast Period 11.3 Endothelial Keratoplasty 11.3.1 Endothelial Keratoplasty market, 2020 - 2028 (USD Million) Figure 45: Endothelial Keratoplasty market, 2020 - 2028 (USD Million) 11.4 Penetrating Keratoplasty 11.4.1 Penetrating Keratoplasty market, 2020 - 2028 (USD Million) Figure 46: Penetrating Keratoplasty market, 2020 - 2028 (USD Million) 11.5 Others 11.5.1 Other Implantation Type market, 2020 - 2028 (USD Million) Figure 47: Other Implantation Type market, 2020 - 2028 (USD Million) Chapter 12. Global Artificial Cornea and Corneal Implant Market: Regional Outlook 12.1 North America Figure 48: North America Artificial Cornea and Corneal Implant Market, By Revenue Forecast (2020-2028) 12.1.1 North America Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) Table 15: North America Artificial Cornea and Corneal Implant Market, by Country, 2020-2028 Figure 49: North America Artificial Cornea and Corneal Implant Market 12.1.2 North America Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Table16: North America Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 50: North America Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.1.3 North America Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Table 17: North America Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 51: North America Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.1.4 North America Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Table 18: North America Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 52: North America Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.1.5 U.S. 12.1.5.1 U.S. Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 53: U.S. Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.1.5.2 U.S. Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 54: U.S. Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.1.5.3 U.S. Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 55: U.S. Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.1.6 Canada 12.1.6.1 Canada Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 56: Canada Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.1.6.2 Canada Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 57: Canada Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.1.6.3 Canada Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 58: Canada Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.1.6.4 Canada Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 59: Canada Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.2 Europe Figure 60: Europe Artificial Cornea and Corneal Implant Market, By Revenue Forecast (2020-2028) 12.2.1 Europe Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) Table 19: Europe Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) Figure 61: Europe Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) 12.2.2 Europe Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Table 20: Europe Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 62: Europe Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.2.3 Europe Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Table 21: Europe Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 63: Europe Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.2.4 Europe Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Table 22: Europe Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 64: Europe Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.2.5 U.K. 12.2.5.1 U.K. Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 65: U.K. Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.2.5.2 U.K. Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 66: U.K. Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.2.5.3 U.K. Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 67: U.K. Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.2.6 Germany 12.2.6.1 Germany Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 68: Germany Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.2.6.2 Germany Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 69: Germany Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.2.6.3 Germany Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 70: Germany Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.2.7 France 12.2.7.1 France Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 71: France Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.2.7.2 France Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 72: France Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.2.7.3 France Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 73: France Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.2.8 Rest of Europe 12.2.8.1 Rest of Europe Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 74: Rest of Europe Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.2.8.2 Rest of Europe Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 75: Rest of Europe Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.2.8.3 Rest of Europe Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 76: Rest of Europe Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.3 Asia Pacific Figure 77: Asia Pacific Artificial Cornea and Corneal Implant Market, By Revenue Forecast (2020-2028) 12.3.1 Asia Pacific Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) Table 23: Asia Pacific Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) Figure 78: Asia Pacific Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) 12.3.2 Asia Pacific Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Table 24: Asia Pacific Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 79: Asia Pacific Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.3.3 Asia Pacific Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Table 25: Asia Pacific Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 80: Asia Pacific Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.3.4 Asia Pacific Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Table 26: Asia Pacific Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 81: Asia Pacific Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.3.5 China 12.3.5.1 China Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 82: China Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.3.5.2 China Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 83: China Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.3.5.3 China Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 84: China Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.3.6 India 12.3.6.1 India Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 85: India Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.3.6.2 India Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 86: India Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.3.6.3 India Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 87: India Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.3.7 Japan 12.3.7.1 Japan Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 88: Japan Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.3.7.2 Japan Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 89: Japan Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.3.7.3 Japan Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 90: Japan Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.3.8 South Korea 12.3.8.1 South Korea Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 91: South Korea Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.3.8.2 South Korea Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 92: South Korea Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.3.8.3 South Korea Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 93: South Korea Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.3.9 Rest of APAC 12.3.9.1 Rest of APAC Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 94: Rest of APAC Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.3.9.2 Rest of APAC Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 95: Rest of APAC Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.3.9.3 Rest of APAC Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 96: Rest of APAC Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.4 Latin America Figure 97: Latin America Artificial Cornea and Corneal Implant Market, By Revenue Forecast (2020-2028) 12.4.1 Latin America Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) Table 27: Latin America Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) Figure 98: Latin America Artificial Cornea and Corneal Implant market, by country, 2020 - 2028 (USD Million) 12.4.2 Latin America Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Table 28: Latin America Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 99: Latin America Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.4.3 Latin America Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Table 29: Latin America Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 100: Latin America Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.4.4 Latin America Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Table 30: Latin America Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 101: Latin America Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.4.5 Brazil 12.4.5.1 Brazil Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 102: Brazil Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.4.5.2 Brazil Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 103: Brazil Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.4.5.3 Brazil Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 104: Brazil Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.4.6 Mexico 12.4.6.1 Mexico Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 105: Mexico Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.4.6 2 Mexico Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 106: Mexico Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.4.6.3 Mexico Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 107: Mexico Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.4.7 Rest of the Latin America 12.4.7.1 Rest of the Latin America Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 108: Rest of the Latin America Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.4.7.2 Rest of the Latin America Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 109: Rest of the Latin America Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.4.7.3 Rest of the Latin America Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 110: Rest of the Latin America Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) 12.5 MEA Figure 111: MEA Artificial Cornea and Corneal Implant Market, By Revenue Forecast (2020-2028) 12.5.1 MEA Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) Figure 112: MEA Artificial Cornea and Corneal Implant market, by Type, 2020 - 2028 (USD Million) 12.5.2 MEA Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) Figure 113: MEA Artificial Cornea and Corneal Implant market, by End-User, 2020 - 2028 (USD Million) 12.5.3 MEA Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Figure 114: MEA Artificial Cornea and Corneal Implant market, by Disease manifestation, 2020 - 2028 (USD Million) Chapter 13. Competitive Landscape 13.1 CorneaGen. 13.1.1 Company overview 13.1.2 Financial performance 13.1.3 Product Portfolio Analysis 13.1.4 Business Strategy & Recent Development 13.2 AJL Ophthalmic. 13.2 .1 Company overview 13.2 .2 Financial performance 13.2 .3 Product Portfolio Analysis 13.2 .4 Business Strategy & Recent Development 13.3 LinkoCare Life Sciences AB. 13.3.1 Company overview 13.3.2 Financial performance 13.3.3 Product Portfolio Analysis 13.3.4 Business Strategy & Recent Development 13.4 Addition Technology. 13.4.1 Company overview 13.4.2 Financial performance 13.4.3 Product Portfolio Analysis 13.4.4 Business Strategy & Recent Development 13.5 Mediphacos. 13.5.1 Company overview 13.5.2 Financial performance 13.5.3 Product Portfolio Analysis 13.5.4 Business Strategy & Recent Development 13.6 Florida Lions Eye Bank. 13.6.1 Company overview 13.6.2 Financial performance 13.6.3 Product Portfolio Analysis 13.6.4 Business Strategy & Recent Development 13.7 Presbia plc. 13.7.1 Company overview 13.7.2 Financial performance 13.7.3 Product Portfolio Analysis 13.7.4 Business Strategy & Recent Development 13.8 Aurolab. 13.8.1 Company overview 13.8.2 Financial performance 13.8.3 Product Portfolio Analysis 13.8.4 Business Strategy & Recent Development 13.9 EyeYon Medical. 13.9.1 Company overview 13.9.2 Financial performance 13.9.3 Product Portfolio Analysis 13.9.4 Business Strategy & Recent Development 13.10 Advancing Sight Network. 13.10.1 Company overview 13.10.2 Financial performance 13.10.3 Product Portfolio Analysis 13.10.4 Business Strategy & Recent Development 13.11 Massachusetts Eye and Ear. 13.11.1 Company overview 13.11.2 Financial performance 13.11.3 Product Portfolio Analysis 13.11.4 Business Strategy & Recent Development 13.12 DIOPTEX GmbH. 13.12.1 Company overview 13.12.2 Financial performance 13.12.3 Product Portfolio Analysis 13.12.4 Business Strategy & Recent Development 13.13 San Diego Eye Bank. 13.13.1 Company overview 13.13.2 Financial performance 13.13.3 Product Portfolio Analysis 13.13.4 Business Strategy & Recent Development 13.14 SightLife. 13.14.1 Company overview 13.14.2 Financial performance 13.14.3 Product Portfolio Analysis 13.14.4 Business Strategy & Recent Development 13.15 Cornea Biosciences. 13.15.1 Company overview 13.15.2 Financial performance 13.15.3 Product Portfolio Analysis 13.15.4 Business Strategy & Recent Development